GraphLogic to Build Custom LIMS for Genetic Services for Sequenom
Branford, CT – USA, September 13, 2006. GraphLogic Inc. announced today that they have been selected by Sequenom, Inc. to create a custom laboratory information management system (LIMS). The LIMS will provide core workflow as part of Sequenom’s commercial genetic analysis services. It will contain complete sample tracking, project management, and inventory control functionality, in addition to reagent tracking and assay setup.
“We are very pleased that Sequenom selected GraphLogic’s software platform for their operational requirements” stated Steven Gold, founder and CEO of GraphLogic. “Our unique platform and development approach, with its end user focused design, improves laboratory productivity, quickly. We will deliver to Sequenom exactly what they request, so they can spend more time focused on generating data to meet customer needs.”
“GraphLogic presented a compelling value proposition for building a LIMS system tailored to fit the specialized needs of our genetic services operations” stated Harry Stylli, Ph.D., President and Chief Executive Officer of Sequenom. “Their custom built system will play an important role as we continue to expand our genetic services.”
“GraphLogic demonstrated their expertise and ability to rapidly build custom software for our scientific operations” stated Jeff Otto, Director of Genetic Services at Sequenom. “Our team appreciated GraphLogic’s unique approach to creating our LIMS system. Their technology provided great flexibility during the design process and we were able to access and test drive the software over the web as it was being created.”
GraphLogic Vice President of Life Sciences, Matthew Roth, added “we are pleased with the results of our pilot project and look forward to moving the software into production.” He also stated, “Our custom software solutions are an excellent fit for Sequenom’s leading genetic analysis applications.”
About GraphLogic Inc.
GraphLogic Inc, headquartered in Branford, CT, provides a development platform and customization services, creating complex applications in less time than it takes to implement off-the-shelf software. With GraphLogic’s software development platform, customers see their applications come to life, over the web, as they develop. GraphLogic custom applications are built for change, keeping pace with business requirements. Customers avoid time consuming and expensive modifications. GraphLogic customers operate in data intensive, high throughput and rapid growth production environments in the Life Sciences, Healthcare, and IT.
For more information on GraphLogic, please visit www.graphlogic.com.
About Sequenom, Inc.
SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and potentially, clinical utility. The Company’s proprietary MassARRAY® system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. The Company has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY® system and other platforms.
For more information on Sequenom, please visit www.sequenom.com.
